BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• FDA

  Sebela Pharmaceuticals Announces FDA Approval of Pizensy™ for oral solution for the Treatment of Chronic Idiopathic Constipation in Adults

  Sebela Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved Pizensy™ (lactitol) for oral solution for the once-daily treatment of chronic idiopathic constipation (CIC) in adults.

  March 11, 2020

   · 

  8 min read
• Genetic test could pick out ‘ultra high risk’ bone marrow cancer patients

  A new genetic test could help doctors pick out patients with the bone marrow cancer multiple myeloma who are at ‘ultra high risk’ of their cancer progressing aggressively early on.

  March 11, 2020

   · 

  5 min read
• Drug Development

  Engage Therapeutics Announces Phase 2b StATES Study of Staccato® Alprazolam for Seizure Cessation Meets Primary Endpoint

  Engage Therapeutics, Inc. announced that its Phase 2b StATES study of Staccato® alprazolam met its primary endpoint which was proportion of responders achieving cessation of seizure activity within two minutes of treatment administration and no recurrence within two hours.

  March 11, 2020

   · 

  4 min read